BCM
IRD

Bridgeway Capital Management’s Opus Genetics IRD Stock Holding History

Bridgeway Capital Management’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$173K Hold
42,065
– – ﹤0.01% 1087
2026
Q1 		$191K Hold
42,065
– – ﹤0.01% 1043
2025
Q4 		$84.6K Hold
42,065
– – ﹤0.01% 1146
2025
Q3 		$69.4K Hold
42,065
– – ﹤0.01% 1142
2025
Q2 		$39.6K Sell
42,065
-74,436
-64% -$69K ﹤0.01% 1141
2025
Q1 		$114K Hold
116,501
– – ﹤0.01% 1012
2024
Q4 		$139K Sell
116,501
-49,250
-30% -$56.5K ﹤0.01% 1064
2024
Q3 		$217K Buy
165,751
+2,010
+1% +$3.1K ﹤0.01% 1044
2024
Q2 		$251K Sell
163,741
-46,200
-22% -$79.9K 0.01% 1002
2024
Q1 		$422K Buy
209,941
+36,605
+21% +$92.8K 0.01% 965
2023
Q4 		$522K Buy
173,336
+131,836
+318% +$390K 0.01% 931
2023
Q3 		$139K Buy
+41,500
New +$167K ﹤0.01% 1160
2019
Q2 		– Sell
-2,148
Closed -$53K – 1400
2019
Q1 		$53K Hold
2,148
– – ﹤0.01% 1311
2018
Q4 		$96K Buy
2,148
+1,042
+94% +$60.9K ﹤0.01% 1311
2018
Q3 		$95K Hold
1,106
– – ﹤0.01% 1385
2018
Q2 		$75K Hold
1,106
– – ﹤0.01% 1380
2018
Q1 		$80K Buy
1,106
+62
+6% +$5.63K ﹤0.01% 1340
2017
Q4 		$101K Buy
+1,044
New +$106K ﹤0.01% 1336
2015
Q3 		– Sell
-375
Closed -$109K – 1539
2015
Q2 		$109K Hold
375
– – ﹤0.01% 1422
2015
Q1 		$131K Hold
375
– – ﹤0.01% 1385
2014
Q4 		$126K Hold
375
– – ﹤0.01% 1364
2014
Q3 		$146K Hold
375
– – ﹤0.01% 1378
2014
Q2 		$157K Hold
375
– – ﹤0.01% 1365
2014
Q1 		$194K Buy
+375
New +$203K 0.01% 1329

Other funds holding IRD

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Bridgeway Capital Management's IRD Position: Q2 2026 in Review

Bridgeway Capital Management held its Opus Genetics (IRD) position steady in Q2 2026 at 42,065 shares worth $173K. The position accounts for ﹤0.01% of the portfolio, ranked #1087.

Bridgeway Capital Management first reported a position in IRD in Q1 2014 and has held it in 24 quarters since. The position peaked at $522K in Q4 2023. 103 funds tracked by Wall St. Rank hold IRD as of Q2 2026.

  • Bridgeway Capital Management held 42,065 shares of Opus Genetics worth $173K as of Q2 2026.
  • Bridgeway Capital Management left its Opus Genetics share count unchanged in Q2 2026.
  • Opus Genetics made up ﹤0.01% of Bridgeway Capital Management's portfolio in Q2 2026, its #1087 holding.
  • Bridgeway Capital Management first reported a position in Opus Genetics in Q1 2014 and has held it in 24 quarters since.
  • Bridgeway Capital Management's Opus Genetics position peaked at $522K in Q4 2023.
  • 103 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.